Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

(2020) Philippe Colson et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

(2020) Clark D Russell et al.   LANCET

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

(2020) Roujian Lu et al.   LANCET

Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases

(2020) Rowan S. Hardy et al.   Nature Reviews Rheumatology

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2

(2020) Renhong Yan et al.   SCIENCE

Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial

(2020) Jesús Villar et al.   Lancet Respiratory Medicine

A Review of SARS-CoV-2 and the Ongoing Clinical Trials

(2020) Yung-Fang Tu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID‐19)

(2020) J. Wu et al.   JOURNAL OF INTERNAL MEDICINE

Clinical course and mortality risk of severe COVID-19

(2020) Paul Weiss et al.   LANCET

Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases

(2020) Cynthia Liu et al.   ACS Central Science

Coronavirus breakthrough: dexamethasone is first drug shown to save lives

(2020) Heidi Ledford   NATURE

Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.

(2020) Mandeep R. Mehra et al.   NEW ENGLAND JOURNAL OF MEDICINE

A study on infectivity of asymptomatic SARS-CoV-2 carriers

(2020) Ming Gao et al.   RESPIRATORY MEDICINE

Dexamethasone in the management of covid -19

(2020) Raymond M Johnson et al.   BMJ-British Medical Journal

Covid-19: Low dose steroid cuts death in ventilated patients by one third, trial finds

(2020) Elisabeth Mahase   BMJ-British Medical Journal

Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus

(2020) Nan Wang et al.   PHYTOMEDICINE

Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome

(2018) Yaseen M. Arabi et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations

(2018) Tricia McKeever et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adjunctive Glucocorticoid Therapy in Patients with Septic Shock

(2018) Balasubramanian Venkatesh et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dual-mixed/CMC model for screening target components from traditional Chinese medicines simultaneously acting on EGFR & FGFR4 receptors

(2018) Jia Fu et al.   TALANTA

Determine equilibrium dissociation constant of drug-membrane receptor affinity using the cell membrane chromatography relative standard method

(2017) Weina Ma et al.   JOURNAL OF CHROMATOGRAPHY A

A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV

(2013) Guangyu Zhao et al.   Virology Journal

Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways

(2012) Emira Ayroldi et al.   FASEB JOURNAL

Glucocorticoid-induced myopathy

(2010) Rosa Maria Rodrigues Pereira et al.   JOINT BONE SPINE

The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights

(2010) Agnes E. Coutinho et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Genomic and nongenomic effects of glucocorticoids

(2008) Cindy Stahn et al.   Nature clinical practice. Rheumatology